Primary & Booster Study to Evaluate the Immunogenicity and Safety of Menitorix Vaccine in Preterm Infants

Clinical trial NCT00586612 · COMPLETED

Trial details

NCT number: NCT00586612
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Haemophilus Influenzae Type b Neisseria Meningitidis

Start date: 2007-12-01
Primary completion: 2008-12-30
Enrollment: 313

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.